Report Overview
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market size was estimated at USD 4364 million in 2023 and is projected to reach USD 9018.79 million by 2032, exhibiting a CAGR of 8.40% during the forecast period.
North America IVD Infectious Disease market size was estimated at USD 1306.78 million in 2023, at a CAGR of 7.20% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global IVD Infectious Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global IVD Infectious Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the IVD Infectious Disease market in any manner.
Global IVD Infectious Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Market Segmentation (by Type)
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Market Segmentation (by Application)
Personal
Commercial
Academic
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the IVD Infectious Disease Market
• Overview of the regional outlook of the IVD Infectious Disease Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the IVD Infectious Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of IVD Infectious Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of IVD Infectious Disease
1.2 Key Market Segments
1.2.1 IVD Infectious Disease Segment by Type
1.2.2 IVD Infectious Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IVD Infectious Disease Market Overview
2.1 Global Market Overview
2.1.1 Global IVD Infectious Disease Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global IVD Infectious Disease Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IVD Infectious Disease Market Competitive Landscape
3.1 Global IVD Infectious Disease Sales by Manufacturers (2019-2025)
3.2 Global IVD Infectious Disease Revenue Market Share by Manufacturers (2019-2025)
3.3 IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global IVD Infectious Disease Average Price by Manufacturers (2019-2025)
3.5 Manufacturers IVD Infectious Disease Sales Sites, Area Served, Product Type
3.6 IVD Infectious Disease Market Competitive Situation and Trends
3.6.1 IVD Infectious Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest IVD Infectious Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IVD Infectious Disease Industry Chain Analysis
4.1 IVD Infectious Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of IVD Infectious Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IVD Infectious Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global IVD Infectious Disease Sales Market Share by Type (2019-2025)
6.3 Global IVD Infectious Disease Market Size Market Share by Type (2019-2025)
6.4 Global IVD Infectious Disease Price by Type (2019-2025)
7 IVD Infectious Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global IVD Infectious Disease Market Sales by Application (2019-2025)
7.3 Global IVD Infectious Disease Market Size (M USD) by Application (2019-2025)
7.4 Global IVD Infectious Disease Sales Growth Rate by Application (2019-2025)
8 IVD Infectious Disease Market Consumption by Region
8.1 Global IVD Infectious Disease Sales by Region
8.1.1 Global IVD Infectious Disease Sales by Region
8.1.2 Global IVD Infectious Disease Sales Market Share by Region
8.2 North America
8.2.1 North America IVD Infectious Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe IVD Infectious Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific IVD Infectious Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America IVD Infectious Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa IVD Infectious Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 IVD Infectious Disease Market Production by Region
9.1 Global Production of IVD Infectious Disease by Region (2019-2025)
9.2 Global IVD Infectious Disease Revenue Market Share by Region (2019-2025)
9.3 Global IVD Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America IVD Infectious Disease Production
9.4.1 North America IVD Infectious Disease Production Growth Rate (2019-2025)
9.4.2 North America IVD Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe IVD Infectious Disease Production
9.5.1 Europe IVD Infectious Disease Production Growth Rate (2019-2025)
9.5.2 Europe IVD Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan IVD Infectious Disease Production (2019-2025)
9.6.1 Japan IVD Infectious Disease Production Growth Rate (2019-2025)
9.6.2 Japan IVD Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China IVD Infectious Disease Production (2019-2025)
9.7.1 China IVD Infectious Disease Production Growth Rate (2019-2025)
9.7.2 China IVD Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Roche Diagnostics
10.1.1 Roche Diagnostics IVD Infectious Disease Basic Information
10.1.2 Roche Diagnostics IVD Infectious Disease Product Overview
10.1.3 Roche Diagnostics IVD Infectious Disease Product Market Performance
10.1.4 Roche Diagnostics Business Overview
10.1.5 Roche Diagnostics IVD Infectious Disease SWOT Analysis
10.1.6 Roche Diagnostics Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories IVD Infectious Disease Basic Information
10.2.2 Abbott Laboratories IVD Infectious Disease Product Overview
10.2.3 Abbott Laboratories IVD Infectious Disease Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories IVD Infectious Disease SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Gen-Probe
10.3.1 Gen-Probe IVD Infectious Disease Basic Information
10.3.2 Gen-Probe IVD Infectious Disease Product Overview
10.3.3 Gen-Probe IVD Infectious Disease Product Market Performance
10.3.4 Gen-Probe IVD Infectious Disease SWOT Analysis
10.3.5 Gen-Probe Business Overview
10.3.6 Gen-Probe Recent Developments
10.4 Becton Dickinson (BD)
10.4.1 Becton Dickinson (BD) IVD Infectious Disease Basic Information
10.4.2 Becton Dickinson (BD) IVD Infectious Disease Product Overview
10.4.3 Becton Dickinson (BD) IVD Infectious Disease Product Market Performance
10.4.4 Becton Dickinson (BD) Business Overview
10.4.5 Becton Dickinson (BD) Recent Developments
10.5 Bio-Rad Laboratories
10.5.1 Bio-Rad Laboratories IVD Infectious Disease Basic Information
10.5.2 Bio-Rad Laboratories IVD Infectious Disease Product Overview
10.5.3 Bio-Rad Laboratories IVD Infectious Disease Product Market Performance
10.5.4 Bio-Rad Laboratories Business Overview
10.5.5 Bio-Rad Laboratories Recent Developments
10.6 Siemens Healthcare
10.6.1 Siemens Healthcare IVD Infectious Disease Basic Information
10.6.2 Siemens Healthcare IVD Infectious Disease Product Overview
10.6.3 Siemens Healthcare IVD Infectious Disease Product Market Performance
10.6.4 Siemens Healthcare Business Overview
10.6.5 Siemens Healthcare Recent Developments
10.7 Biomérieux
10.7.1 Biomérieux IVD Infectious Disease Basic Information
10.7.2 Biomérieux IVD Infectious Disease Product Overview
10.7.3 Biomérieux IVD Infectious Disease Product Market Performance
10.7.4 Biomérieux Business Overview
10.7.5 Biomérieux Recent Developments
10.8 Danaher
10.8.1 Danaher IVD Infectious Disease Basic Information
10.8.2 Danaher IVD Infectious Disease Product Overview
10.8.3 Danaher IVD Infectious Disease Product Market Performance
10.8.4 Danaher Business Overview
10.8.5 Danaher Recent Developments
10.9 Thermo Fisher
10.9.1 Thermo Fisher IVD Infectious Disease Basic Information
10.9.2 Thermo Fisher IVD Infectious Disease Product Overview
10.9.3 Thermo Fisher IVD Infectious Disease Product Market Performance
10.9.4 Thermo Fisher Business Overview
10.9.5 Thermo Fisher Recent Developments
10.10 Sysmex
10.10.1 Sysmex IVD Infectious Disease Basic Information
10.10.2 Sysmex IVD Infectious Disease Product Overview
10.10.3 Sysmex IVD Infectious Disease Product Market Performance
10.10.4 Sysmex Business Overview
10.10.5 Sysmex Recent Developments
11 IVD Infectious Disease Market Forecast by Region
11.1 Global IVD Infectious Disease Market Size Forecast
11.2 Global IVD Infectious Disease Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe IVD Infectious Disease Market Size Forecast by Country
11.2.3 Asia Pacific IVD Infectious Disease Market Size Forecast by Region
11.2.4 South America IVD Infectious Disease Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of IVD Infectious Disease by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global IVD Infectious Disease Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of IVD Infectious Disease by Type (2025-2032)
12.1.2 Global IVD Infectious Disease Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of IVD Infectious Disease by Type (2025-2032)
12.2 Global IVD Infectious Disease Market Forecast by Application (2025-2032)
12.2.1 Global IVD Infectious Disease Sales (K Units) Forecast by Application
12.2.2 Global IVD Infectious Disease Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. IVD Infectious Disease Market Size Comparison by Region (M USD)
Table 5. Global IVD Infectious Disease Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global IVD Infectious Disease Sales Market Share by Manufacturers (2019-2025)
Table 7. Global IVD Infectious Disease Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global IVD Infectious Disease Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2022)
Table 10. Global Market IVD Infectious Disease Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers IVD Infectious Disease Sales Sites and Area Served
Table 12. Manufacturers IVD Infectious Disease Product Type
Table 13. Global IVD Infectious Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of IVD Infectious Disease
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. IVD Infectious Disease Market Challenges
Table 22. Global IVD Infectious Disease Sales by Type (K Units)
Table 23. Global IVD Infectious Disease Market Size by Type (M USD)
Table 24. Global IVD Infectious Disease Sales (K Units) by Type (2019-2025)
Table 25. Global IVD Infectious Disease Sales Market Share by Type (2019-2025)
Table 26. Global IVD Infectious Disease Market Size (M USD) by Type (2019-2025)
Table 27. Global IVD Infectious Disease Market Size Share by Type (2019-2025)
Table 28. Global IVD Infectious Disease Price (USD/Unit) by Type (2019-2025)
Table 29. Global IVD Infectious Disease Sales (K Units) by Application
Table 30. Global IVD Infectious Disease Market Size by Application
Table 31. Global IVD Infectious Disease Sales by Application (2019-2025) & (K Units)
Table 32. Global IVD Infectious Disease Sales Market Share by Application (2019-2025)
Table 33. Global IVD Infectious Disease Sales by Application (2019-2025) & (M USD)
Table 34. Global IVD Infectious Disease Market Share by Application (2019-2025)
Table 35. Global IVD Infectious Disease Sales Growth Rate by Application (2019-2025)
Table 36. Global IVD Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 37. Global IVD Infectious Disease Sales Market Share by Region (2019-2025)
Table 38. North America IVD Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 39. Europe IVD Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific IVD Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 41. South America IVD Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa IVD Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 43. Global IVD Infectious Disease Production (K Units) by Region (2019-2025)
Table 44. Global IVD Infectious Disease Revenue (US$ Million) by Region (2019-2025)
Table 45. Global IVD Infectious Disease Revenue Market Share by Region (2019-2025)
Table 46. Global IVD Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America IVD Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe IVD Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan IVD Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China IVD Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Roche Diagnostics IVD Infectious Disease Basic Information
Table 52. Roche Diagnostics IVD Infectious Disease Product Overview
Table 53. Roche Diagnostics IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Roche Diagnostics Business Overview
Table 55. Roche Diagnostics IVD Infectious Disease SWOT Analysis
Table 56. Roche Diagnostics Recent Developments
Table 57. Abbott Laboratories IVD Infectious Disease Basic Information
Table 58. Abbott Laboratories IVD Infectious Disease Product Overview
Table 59. Abbott Laboratories IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories IVD Infectious Disease SWOT Analysis
Table 62. Abbott Laboratories Recent Developments
Table 63. Gen-Probe IVD Infectious Disease Basic Information
Table 64. Gen-Probe IVD Infectious Disease Product Overview
Table 65. Gen-Probe IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Gen-Probe IVD Infectious Disease SWOT Analysis
Table 67. Gen-Probe Business Overview
Table 68. Gen-Probe Recent Developments
Table 69. Becton Dickinson (BD) IVD Infectious Disease Basic Information
Table 70. Becton Dickinson (BD) IVD Infectious Disease Product Overview
Table 71. Becton Dickinson (BD) IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Becton Dickinson (BD) Business Overview
Table 73. Becton Dickinson (BD) Recent Developments
Table 74. Bio-Rad Laboratories IVD Infectious Disease Basic Information
Table 75. Bio-Rad Laboratories IVD Infectious Disease Product Overview
Table 76. Bio-Rad Laboratories IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories Recent Developments
Table 79. Siemens Healthcare IVD Infectious Disease Basic Information
Table 80. Siemens Healthcare IVD Infectious Disease Product Overview
Table 81. Siemens Healthcare IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Siemens Healthcare Business Overview
Table 83. Siemens Healthcare Recent Developments
Table 84. Biomérieux IVD Infectious Disease Basic Information
Table 85. Biomérieux IVD Infectious Disease Product Overview
Table 86. Biomérieux IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Biomérieux Business Overview
Table 88. Biomérieux Recent Developments
Table 89. Danaher IVD Infectious Disease Basic Information
Table 90. Danaher IVD Infectious Disease Product Overview
Table 91. Danaher IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Danaher Business Overview
Table 93. Danaher Recent Developments
Table 94. Thermo Fisher IVD Infectious Disease Basic Information
Table 95. Thermo Fisher IVD Infectious Disease Product Overview
Table 96. Thermo Fisher IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Thermo Fisher Business Overview
Table 98. Thermo Fisher Recent Developments
Table 99. Sysmex IVD Infectious Disease Basic Information
Table 100. Sysmex IVD Infectious Disease Product Overview
Table 101. Sysmex IVD Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Sysmex Business Overview
Table 103. Sysmex Recent Developments
Table 104. Global IVD Infectious Disease Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global IVD Infectious Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America IVD Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America IVD Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe IVD Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe IVD Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific IVD Infectious Disease Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific IVD Infectious Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America IVD Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America IVD Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa IVD Infectious Disease Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa IVD Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global IVD Infectious Disease Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global IVD Infectious Disease Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global IVD Infectious Disease Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global IVD Infectious Disease Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global IVD Infectious Disease Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of IVD Infectious Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global IVD Infectious Disease Market Size (M USD), 2019-2032
Figure 5. Global IVD Infectious Disease Market Size (M USD) (2019-2032)
Figure 6. Global IVD Infectious Disease Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. IVD Infectious Disease Market Size by Country (M USD)
Figure 11. IVD Infectious Disease Sales Share by Manufacturers in 2023
Figure 12. Global IVD Infectious Disease Revenue Share by Manufacturers in 2023
Figure 13. IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market IVD Infectious Disease Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by IVD Infectious Disease Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global IVD Infectious Disease Market Share by Type
Figure 18. Sales Market Share of IVD Infectious Disease by Type (2019-2025)
Figure 19. Sales Market Share of IVD Infectious Disease by Type in 2023
Figure 20. Market Size Share of IVD Infectious Disease by Type (2019-2025)
Figure 21. Market Size Market Share of IVD Infectious Disease by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global IVD Infectious Disease Market Share by Application
Figure 24. Global IVD Infectious Disease Sales Market Share by Application (2019-2025)
Figure 25. Global IVD Infectious Disease Sales Market Share by Application in 2023
Figure 26. Global IVD Infectious Disease Market Share by Application (2019-2025)
Figure 27. Global IVD Infectious Disease Market Share by Application in 2023
Figure 28. Global IVD Infectious Disease Sales Growth Rate by Application (2019-2025)
Figure 29. Global IVD Infectious Disease Sales Market Share by Region (2019-2025)
Figure 30. North America IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America IVD Infectious Disease Sales Market Share by Country in 2023
Figure 32. U.S. IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada IVD Infectious Disease Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico IVD Infectious Disease Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe IVD Infectious Disease Sales Market Share by Country in 2023
Figure 37. Germany IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific IVD Infectious Disease Sales and Growth Rate (K Units)
Figure 43. Asia Pacific IVD Infectious Disease Sales Market Share by Region in 2023
Figure 44. China IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America IVD Infectious Disease Sales and Growth Rate (K Units)
Figure 50. South America IVD Infectious Disease Sales Market Share by Country in 2023
Figure 51. Brazil IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa IVD Infectious Disease Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa IVD Infectious Disease Sales Market Share by Region in 2023
Figure 56. Saudi Arabia IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa IVD Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global IVD Infectious Disease Production Market Share by Region (2019-2025)
Figure 62. North America IVD Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe IVD Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan IVD Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 65. China IVD Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 66. Global IVD Infectious Disease Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global IVD Infectious Disease Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global IVD Infectious Disease Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global IVD Infectious Disease Market Share Forecast by Type (2025-2032)
Figure 70. Global IVD Infectious Disease Sales Forecast by Application (2025-2032)
Figure 71. Global IVD Infectious Disease Market Share Forecast by Application (2025-2032)
